Benefit-risk balance for marketed drugs: evaluating safety signals
Сохранить в:
| Соавтор: | Council for International Organizations of Medical Sciences (CIOMS) |
|---|---|
| Формат: | |
| Язык: | English |
| Опубликовано: |
Geneva
Council for International Organizations of Medical Sciences (CIOMS)
1998
|
| Предметы: | |
| Online-ссылка: | Visit NHRC Library |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Схожие документы
-
Martindale: the complete drug reference
по: Parfitt, Kathleen
Опубликовано: (1999) -
WHO drug information.
Опубликовано: (2000) -
WHO expert committee on specifications for pharmaceutical preparations
Опубликовано: (2006) -
International nonproprietary names (INN) for pharmaceutical substances : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Опубликовано: (1992) -
WHO expert committee on specifications for pharmaceutical preparations
Опубликовано: (2011)